677 related articles for article (PubMed ID: 12622582)
21. SNAPPE-II and risk of neonatal morbidities in very low birth weight preterm infants.
Özcan B; Kavurt AS; Aydemir Ö; Gençtürk Z; Baş AY; Demirel N
Turk J Pediatr; 2017; 59(2):105-112. PubMed ID: 29276862
[TBL] [Abstract][Full Text] [Related]
22. [The morbidities of extremely preterm and extremely low birth weight infants during hospitalization].
;
Zhonghua Er Ke Za Zhi; 2015 May; 53(5):334-40. PubMed ID: 26080662
[TBL] [Abstract][Full Text] [Related]
23. Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: further analyses from the Trial of Indomethacin Prophylaxis in Preterms (TIPP).
Schmidt B; Roberts RS; Fanaroff A; Davis P; Kirpalani HM; Nwaesei C; Vincer M;
J Pediatr; 2006 Jun; 148(6):730-734. PubMed ID: 16769377
[TBL] [Abstract][Full Text] [Related]
24. Identifying Risk Factors Shared by Bronchopulmonary Dysplasia, Severe Retinopathy, and Cystic Periventricular Leukomalacia in Very Preterm Infants for Targeted Intervention.
Wang LW; Lin YC; Wang ST; Huang CC;
Neonatology; 2018; 114(1):17-24. PubMed ID: 29621770
[TBL] [Abstract][Full Text] [Related]
25. Sildenafil and Retinopathy of Prematurity in Preterm Infants with Bronchopulmonary Dysplasia.
Aboudi D; Swaminathan N; Brumberg H; Shi Q; Friedman D; Parvez B; Krishnan U
J Pediatr; 2018 Aug; 199():16-21. PubMed ID: 29753546
[TBL] [Abstract][Full Text] [Related]
26. Cohort study of growth patterns by gestational age in preterm infants developing morbidity.
Klevebro S; Lundgren P; Hammar U; Smith LE; Bottai M; Domellöf M; Löfqvist C; Hallberg B; Hellström A
BMJ Open; 2016 Nov; 6(11):e012872. PubMed ID: 27856479
[TBL] [Abstract][Full Text] [Related]
27. Association between early postnatal weight loss and death or BPD in small and appropriate for gestational age extremely low-birth-weight infants.
Wadhawan R; Oh W; Perritt R; Laptook AR; Poole K; Wright LL; Fanaroff AA; Duara S; Stoll BJ; Goldberg R
J Perinatol; 2007 Jun; 27(6):359-64. PubMed ID: 17443198
[TBL] [Abstract][Full Text] [Related]
28. Mid- and long-term outcome of extremely low birth weight (ELBW) infants: an analysis of prognostic factors.
Valcamonico A; Accorsi P; Sanzeni C; Martelli P; La Boria P; Cavazza A; Frusca T
J Matern Fetal Neonatal Med; 2007 Jun; 20(6):465-71. PubMed ID: 17674256
[TBL] [Abstract][Full Text] [Related]
29. Fluid restriction and prophylactic indomethacin versus prophylactic indomethacin alone for prevention of morbidity and mortality in extremely low birth weight infants.
Anabrees J; Alfaleh K
Cochrane Database Syst Rev; 2011 Jul; (7):CD007604. PubMed ID: 21735414
[TBL] [Abstract][Full Text] [Related]
30. Hospital variation and risk factors for bronchopulmonary dysplasia in a population-based cohort.
Lapcharoensap W; Gage SC; Kan P; Profit J; Shaw GM; Gould JB; Stevenson DK; O'Brodovich H; Lee HC
JAMA Pediatr; 2015 Feb; 169(2):e143676. PubMed ID: 25642906
[TBL] [Abstract][Full Text] [Related]
31. Neonatal hematological parameters and the risk of moderate-severe bronchopulmonary dysplasia in extremely premature infants.
Chen X; Li H; Qiu X; Yang C; Walther FJ
BMC Pediatr; 2019 Apr; 19(1):138. PubMed ID: 31039810
[TBL] [Abstract][Full Text] [Related]
32. [Clinical characteristics and risk factors of very low birth weight and extremely low birth weight infants with bronchopulmonary dysplasia: multicenter retrospective analysis].
Jiangsu Multicenter Study Collaborative Group for Breastmilk Feeding in Neonatal Intensive Care Units
Zhonghua Er Ke Za Zhi; 2019 Jan; 57(1):33-39. PubMed ID: 30630229
[No Abstract] [Full Text] [Related]
33. The outcome at 12 months of very-low-birth-weight infants ventilated at Tygerberg Hospital.
Kirsten GF; van Zyl JI; le Grange M; Ancker E; van Zyl F
S Afr Med J; 1995 Jul; 85(7):649-54. PubMed ID: 7482082
[TBL] [Abstract][Full Text] [Related]
34. Indomethacin prophylaxis or expectant treatment of patent ductus arteriosus in extremely low birth weight infants?
Cordero L; Nankervis CA; Delooze D; Giannone PJ
J Perinatol; 2007 Mar; 27(3):158-63. PubMed ID: 17251986
[TBL] [Abstract][Full Text] [Related]
35. Outcomes of extremely low birth weight (<1 kg) and extremely low gestational age (<28 weeks) infants with bronchopulmonary dysplasia: effects of practice changes in 2000 to 2003.
Kobaly K; Schluchter M; Minich N; Friedman H; Taylor HG; Wilson-Costello D; Hack M
Pediatrics; 2008 Jan; 121(1):73-81. PubMed ID: 18166559
[TBL] [Abstract][Full Text] [Related]
36. Epidemiological factors involved in the development of bronchopulmonary dysplasia in very low birth-weight preterm infants.
Lardón-Fernández M; Uberos J; Molina-Oya M; Narbona-López E
Minerva Pediatr; 2017 Feb; 69(1):42-49. PubMed ID: 25715027
[TBL] [Abstract][Full Text] [Related]
37. Length at birth z-score is inversely associated with an increased risk of bronchopulmonary dysplasia or death in preterm infants born before 32 gestational weeks: A nationwide cohort study.
Jung YH; Park Y; Kim BI; Choi CW
PLoS One; 2019; 14(5):e0217739. PubMed ID: 31150480
[TBL] [Abstract][Full Text] [Related]
38. Early energy and protein intakes and associations with growth, BPD, and ROP in extremely preterm infants.
Klevebro S; Westin V; Stoltz Sjöström E; Norman M; Domellöf M; Edstedt Bonamy AK; Hallberg B
Clin Nutr; 2019 Jun; 38(3):1289-1295. PubMed ID: 29885776
[TBL] [Abstract][Full Text] [Related]
39. Long-Term Effects of Inhaled Budesonide for Bronchopulmonary Dysplasia.
Bassler D; Shinwell ES; Hallman M; Jarreau PH; Plavka R; Carnielli V; Meisner C; Engel C; Koch A; Kreutzer K; van den Anker JN; Schwab M; Halliday HL; Poets CF;
N Engl J Med; 2018 Jan; 378(2):148-157. PubMed ID: 29320647
[TBL] [Abstract][Full Text] [Related]
40. Neonatal outcomes of preterm or very-low-birth-weight infants over a decade from Queen Mary Hospital, Hong Kong: comparison with the Vermont Oxford Network.
Chee YY; Wong MS; Wong RM; Wong KY
Hong Kong Med J; 2017 Aug; 23(4):381-6. PubMed ID: 28684649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
